ATAGI and the AHPPC have stepped up their vaccination advice, ahead of an expected surge in both COVID and influenza this winter season.
ATAGI has recommended a winter booster dose of COVID vaccine from April 2022 to increase vaccine protection for selected groups at greatest risk of severe illness from COVID. For other groups, ATAGI will continue to monitor emerging evidence and may recommend an additional dose in the future. For anyone aged 16 and older who has not yet received their first booster dose, ATAGI recommends they receive it as soon as possible.
Everyone in the community is also being urged to take up the 2022 influenza vaccine available from April 2022, after two years of minimal influenza transmission in Australia. ATAGI has advised that the influenza vaccine can be co-administered with the COVID winter booster dose or given ahead of time if the person is not yet eligible for the booster. The AHPPC is also encouraging influenza vaccination for the 6-month to 5-year age group not eligible for COVID vaccine.
To help doctors navigate the many challenges associated with managing COVID and the vaccination rollout, we have compiled responses to members’ FAQs. These are regularly updated below: